Eisai and Biogen announced that Eisai has initiated a rolling submission to the US Food and Drug Administration (FDA) of a Biologics License Application (BLA) for lecanemab (BAN2401), the company’s investigational anti-amyloid beta (Aß) protofibril antibody, for the treatment of early Alzheimer’s disease (early AD).

A new self-exclusion program, PlayPause from Conscious Gaming, would create a cross-jurisdictional database to keep gamblers who can’t play in one place from jumping to another.

There may be a light at the end of the tunnel.

In a welcome change of behavior and social progress, individuals are now more willing to promote mental health in the same way that physical health has long been prioritized.

Millions of Americans have traded traditional work wardrobes for loungewear in the nearly two years of working remotely during the pandemic.

MGM Resorts International announced an agreement with Blackstone to acquire the operations of The Cosmopolitan of Las Vegas.

MGM Resorts International announced an agreement with Blackstone to acquire the operations of The Cosmopolitan of Las Vegas.

Optimistic about the drug’s efficacy, the company has initiated its submission for accelerated FDA approval.